Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Flavia Matovu Kiweewa(MUJHU Research Collaboration), Pearl Selepe(Aurum Institute), Dhayendre Moodley(Centre for the AIDS Programme of Research in South Africa), Gonasagrie Nair, Vimla Naicker(South African Medical Research Council), Alexander Kintu(Harvard Global Health Institute), Nishanta Singh(South African Medical Research Council), Ishana Harkoo(Centre for the AIDS Programme of Research in South Africa), Limakatso Lebina(Perinatal HIV Research Unit), Yashna Singh, Joanne Batting(Centre for the AIDS Programme of Research in South Africa), Elizabeth Spooner(South African Medical Research Council), Ravindre Panchia(Chris Hani Baragwanath Hospital), Philip Kotze(Jisc), William Brumskine(Aurum Institute), Jared M. Baeten(University of Washington), Thesla Palanee‐Phillips(University of the Witwatersrand), Saresha Pillay(Centre for the AIDS Programme of Research in South Africa), Khatija Ahmed(University of California, San Francisco), Quarraisha Abdool Karim(Centre for the AIDS Programme of Research in South Africa), Christoph C Carter(Centre for the AIDS Programme of Research in South Africa), Leila E. Mansoor(Centre for the AIDS Programme of Research in South Africa), Moupali Das(University of California, San Francisco), Moelo Malahleha, Mmatsie Manentsa, Noah Kiwanuka(Centre for the AIDS Programme of Research in South Africa), Disebo Potloane, Zwelethu Zwane(Centre for the AIDS Programme of Research in South Africa), Yang Zhao(Shenzhen University), Amy Ward(University of Cape Town), Megeshinee Naidoo(Centre for the AIDS Programme of Research in South Africa), Nkosiphile Ndlovu(Centre for the AIDS Programme of Research in South Africa), Katherine Gill, Chris Deaton(Centre for the AIDS Programme of Research in South Africa), Cheryl Louw, Logashvari Naidoo(South African Medical Research Council), Manjeetha Jaggernath(Centre for the AIDS Programme of Research in South Africa), Godfrey Kigozi(Rakai Health Sciences Program), Ramin Ebrahimi(Gilead Sciences (United States))
Cited by 471
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities
|The Open AIDS Journal|2016|994
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768